KQ-791

DRUG2 trials

Sponsors

Kaneq Bioscience Limited

Conditions

Diabetes Mellitus, Type 2Healthy VolunteersInsulin Resistance

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791

CompletedNCT02370043

Kaneq Bioscience LimitedHealthy Volunteers, Insulin Resistance

Start: 2015-02-28End: 2015-07-31Updated: 2019-11-26

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus

CompletedNCT02445911

Kaneq Bioscience LimitedDiabetes Mellitus, Type 2

Start: 2015-06-30End: 2016-02-29Updated: 2019-11-26